Abstract
Objective We aimed to evaluate how acceptable paediatric Long COVID services were to patients and clinicians. This paper focuses on how acceptable Long COVID services were to paediatric patients.
Design This study was explorational. Semi-structured qualitative interviews with 13 paediatric patients were used to understand the experiences of patients with Long COVID.
Setting Participants were recruited from specialist paediatric services in the Southwest of England from June 2022 to September 2023.
Patients Participants were children and young people (CYP) aged 11-17 years old with a Long COVID diagnosis who accessed the specialist services in the Southwest of England.
Results Four themes were reported. Accessing specialist clinics helped CYP to feel validated, they appreciated consulting with clinicians who were knowledgeable about Long COVID and empathetic. CYP found comfort in knowing other CYP were experiencing Long COVID. CYP wanted to be proactive in their Long COVID management, appreciating regular appointments and the opportunity to learn about their condition. CYP desired normality, and therefore sought flexible appointment times, online appointments, and reasonable adjustments. CYP found the waiting times to access Long COVID services were too long.
Conclusions Our results stress the importance to CYP of several features of the care received in the specialist clinics. These relate to the experiences of CYP with Long COVID but potentially extend to CYP with other conditions, particularly long-term and/or poorly understood conditions. The results support creating community-based support groups for CYP with long-term medical conditions, providing online flexible appointments, offering early reasonable adjustments for school and providing quicker access to specialist clinics.
What is already known on this topic The existing literature which explores adult experiences of Long COVID services is in agreement with this study in multiple ways. Firstly, it appears that clinician validation is very important to the clinician patient relationship (1-5). Peer support and building a Long COVID community for patients is also valued by individuals with Long COVID (1, 3, 5, 6), as are online appointments (1,3). Finally, long waiting lists to access Long COVID clinics are a barrier to care (1, 3). This can be mitigated to some extent by providing sign-posting or self-management resources while waiting for clinic access (3). However, the literature regarding paediatric experiences of Long COVID is limited. Two papers discuss the impact of a lack of reasonable adjustments on school (7,8) and the importance of validation through peer support (7).
What this study adds To the best of our knowledge, there are no studies on Long COVID services for paediatric patients that highlight how patients experienced management of their condition. Our study highlights the patient’s desire to be proactive in their management, including being given opportunities to learn about Long COVID.
How this study might affect research, practice or policy This study highlights recommendations for clinical practice. It is recommended to consider the following when designing specialist paediatric services for CYP with Long COVID: CYP with complex medical conditions want clinicians to validate their experience by acknowledging that their symptoms are real and their concerns are valid. Community-based groups for CYP experiencing the same condition are valued by patients, as are online flexible appointments, liaison with schools to provide early reasonable adjustments and rapid access to services for CYP. Future research should explore how these recommendations positively impact patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr Olivia Taylor recieved a grant from the Wolfson Foundation to allow her to intercalate. The Wolfson Foundation describes this as 'Funding administered by the Royal College of Physicians for outstanding undergraduate students at selected medical schools who are likely to pursue a medical research career. These awards enable students to take a one-year academic course part-way through their medical degree.' We recieved a grant from RNHRD sub-committee of Charitable Funds.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Health and Care Research Wales (HCRW) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript or supplementary materials.
